#VELA Vela Technologies PLC – Update re. Economic Interest in AZD1656 May 15, 2023 – Posted in: Blog, Vela Technologies Plc (VELA) – Tags: , , , , , , ,

Further to the Company’s announcement on 20 April 2023, the Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, notes the Form S-4 Registration Statement and preliminary proxy statement filed by Murphy Canyon Acquisition Corp. (NASDAQ: MURF) on 12 May 2023 which is available for viewing on the United States Securities and Exchange Commission’s website.

 

On 20 April 2023, Vela announced that the Company entered into a put option agreement to give the Company the right, but not the obligation (“the Option”), to sell its economic interest in the commercialisation of the Covid-19 application of AZD1656 for a total consideration of £4.0 million. The Option was granted by Conduit Pharmaceuticals Limited (“Conduit”) and its prospective parent company, Murphy Canyon Acquisition Corp. (“Murphy”), a Company listed on NASDAQ.

 

As previously announced on 20 April 2023, the Board of Vela is mindful that there can be no guarantee that Vela will be able to exercise the Option, since exercise is dependent on the successful completion of the merger between Conduit and Murphy and the combined entity being listed on the NASDAQ stock exchange.

 

A copy of the Form S-4 Registration Statement can be found at:

 

https://www.sec.gov/ix?doc=/Archives/edgar/data/1896212/000149315223016741/forms-4.htm

 

The Company will release further announcements as and when appropriate.

For further information, please contact:

Vela Technologies plc

Brent Fitzpatrick, Non-Executive Chairman

James Normand, Executive Director

Tel: +44 (0) 7410 886830

 

Allenby Capital Limited (Nominated Adviser)

Tel: +44 (0) 20 3328 5656

Nick Athanas / Piers Shimwell

Peterhouse Capital Limited (Broker)

Tel: +44 (0) 20 7469 0930

Lucy Williams / Duncan Vasey / Eran Zucker / Oryon Lass

Novus Communications (PR and IR Adviser)

Tel: +44 (0) 20 7448 9839

Alan Green / Jacqueline Briscoe